higher dose semaglutide The FDA has approved a new (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Novo Nordisk study finds greater

However, this would need to be confirmed in a head-to-head trial to come to a firm conclusion

A research piece in JAMA from January 2025, examining over 125,000 individuals who were overweight or obese, indicated that almost 47% of participants with type 2 diabetes and 65% without diabetes ceased using their prescribed GLP-1s within twelve months of initiation

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)

176, e14126

The Bottom Line STDEI GLP-1 Oral Solution Drops are marketed with false promises, fake endorsements, misleading certifications, and scripted testimonials